Furthermore, to identify that miR-326 treatment and CTL recognition synergized to kill glioma cells through a TGF-β1-mediated mechanism, we pre-incubated U87-EGFRvIII cells with rhTGF-β1 or medium for 12 hours. Here, TGFB1 is linked to central nervous system cancer.